Genetic Technologies Limited (ADR) (NASDAQ: GENE) shares soared toward 100% gains today after the company announced it received certification of its Australian laboratory, under the U.S. Clinical Laboratories Improvements Amendments (CLIA) regulated by the Centers for Medicare and Medicaid. The certification completes the requirements for the U.S. launch of the BREVAGen breast cancer test. The [...]
Articles published by investor16
Trending Biotech Play; Cell Therapeutics Q1 Earnings Review
Cell Therapeutics Inc. (NASDAQ: CTIC) shares slipped in this morning’s trade after the biotech play reported accomplishments and financial results for the first quarter of 2011. Cell Therapeutics reported a net loss of $51.0 million ($0.06 per share) for the quarter as compared to a net loss of $44.2 million ($0.07 per share) for the [...]
PeopleString launches PeopleDeals to Drive Social Marketing
PeopleString Corporation (OTC: PLPE) plummeted 16% today despite news the company has launched PeopleDeals, a social coupon platform that allows merchants to launch real-time social media marketing campaigns and, through its shareItUp feature, offer deals that grow in value as they are shared via social networks, email or text. The platform uses social media, mobile [...]
Earnings Review; Bucyrus Q1 Financials
Bucyrus International Inc. (NASDAQ: BUCY) recently reported strong financial numbers for its first fiscal quarter of the year. The company reported that its net profit for the quarter increased 61% . Bucyrus announced that it experienced higher demand for its products in Australia, North Africa, China and India. The company reported its net earnings for [...]
Tasty Baking soars on Sweet Merger Agreement with Flowers Foods
Tasty Baking Company (NASDAQ: TSTY) shares soared more than 100% in today’s trading after the company entered into a definitive merger agreement with Flowers Foods (NYSE: FLO), in which Flowers will acquire all outstanding shares of Tasty for $4 per share in cash. The transaction is valued at $165 million, including Tasty Baking debt. The [...]
$2.9B Price Tag; Endo Pharmaceuticals to acquire American Medical Systems
Shares of Endo Pharmaceuticals (NASDAQ: ENDP) and American Medical Systems (NASDAQ: AMMD) are on the move after Endo announced it will acquire American Medical for $30 per share in an all cash deal in a deal valued at $2.9 billion, including the assumption and repayment of $312 million in American Medical Systems debt. The combination [...]
Casino Stock Melco Crown on a Roll after JP Morgan Raises Price Target
Melco Crown Entertainment Ltd (ADR) (NASDAQ: MPEL) is climbing in today’s trading after JP Morgan analyst Joseph Greff craised the price target on the company’s share. Greff raised the price target citing Asia strength, raising the price target for Melco Crown shares from $8 to $9 while at the same time raising the company’s first-quarter [...]
Healthcare Technology Stock; Medtronic FDA News
Medtronic Inc. (NYSE: MDT) this morning announced the U.S. Food and Drug Administration (FDA) has given the OK for the market launch of CareLink® Personal 5.4 Therapy Management Software for the Mac OS platform. CareLink Personal is a Web-based program that helps people with diabetes assess their glucose control through easy-to-read reports, charts and graphs. [...]
Airline Stock Review; 3 Industry Stocks to keep an Eye on
AMR Corporation (NYSE: AMR) announced recently that it has entered into a contract with Japan Airlines. The deal will involve the launch of a new trans-pacific alliance. The deal will allow the airlines to coordinate their schedules and to set their fares. The company stock is currently trading at $6.40, down 0.93% from its previous [...]
CytoSorbents Skyrockets +120% on EU Approval
CytoSorbents Corporation (OTC: CTSO) shares finished the day up 128% on word that it has received regulatory approval from the European Union for the company’s flagship product CytoSorb. CytoSorb is a filter used in the case of excessive levels of cytokine. The approval shows that the company product has met label efficacy and safety claim [...]